Publication | Closed Access

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial

ThrombosisPatient SafetyGastroenterologyRecurrent Ulcer BleedingHemostasisProton-pump InhibitorPharmacotherapyBleeding DisorderMedicineAtherosclerosisEmergency MedicineAnesthesiologyHigh Risk